Terig Hughes

CIK: 0001841309

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VNRX

VOLITIONRX LTD

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

VNRX
VOLITIONRX LTD
Feb 26, 2026
Award(A)
Direct
202K shares-
VNRX
VOLITIONRX LTD
Jan 22, 2026
Award(A)
Direct
49.2K shares-
VNRX
VOLITIONRX LTD
Aug 15, 2025
Award(A)
Direct
26.1K shares-
VNRX
VOLITIONRX LTD
Jul 24, 2025
Award(A)
Direct
100K shares-
VNRX
VOLITIONRX LTD
Jun 1, 2025
Award(A)
Direct
17.4K shares-
VNRX
VOLITIONRX LTD
Mar 1, 2025
Award(A)
Direct
14K shares-
VNRX
VOLITIONRX LTD
Dec 1, 2024
Award(A)
Direct
12.7K shares-
VNRX
VOLITIONRX LTD
Sep 1, 2024
Award(A)
Direct
13.5K shares-

		Type	Shares	Price		Ownership
Feb 26, 2026	VNRX VOLITIONRX LTD	Award(A)	202,000	-	$0	Direct
Jan 22, 2026	VNRX VOLITIONRX LTD	Award(A)	49,200	-	$0	Direct
Aug 15, 2025	VNRX VOLITIONRX LTD	Award(A)	26,143	-	-	Direct
Jul 24, 2025	VNRX VOLITIONRX LTD	Award(A)	100,000	-	-	Direct
Jun 1, 2025	VNRX VOLITIONRX LTD	Award(A)	17,406	-	-	Direct
Mar 1, 2025	VNRX VOLITIONRX LTD	Award(A)	13,969	-	-	Direct
Dec 1, 2024	VNRX VOLITIONRX LTD	Award(A)	12,683	-	$0	Direct
Sep 1, 2024	VNRX VOLITIONRX LTD	Award(A)	13,493	-	$0	Direct

1-8 of 8 transactions

About Hughes Terig

Hughes Terig (SEC CIK 0001841309) files insider reports with the SEC as Chief Financial Officer of VOLITIONRX LTD (VNRX).

Signal8 holds 8 ownership filings by Hughes Terig, all Form 4s, filed between Sep 4, 2024 and Feb 27, 2026. Those filings report 8 transactions, from Sep 1, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hughes Terig's filings is in HENDERSON, NV.

Recent filings by Hughes Terig

Feb 26, 2026: Grant or award of VNRX shares (Form 4, code A).
Jan 22, 2026: Grant or award of VNRX shares (Form 4, code A).
Aug 15, 2025: Grant or award of VNRX shares (Form 4, code A).
Jul 24, 2025: Grant or award of VNRX shares (Form 4, code A).
Jun 1, 2025: Grant or award of VNRX shares (Form 4, code A).

Other insiders filing for VOLITIONRX LTD (VNRX)

Batchelor Ann-Louise, Group Chief Marketing Officer
Forterre Gael, Chief Commercial Officer
Rootsaert Rodney Gerard, Secretary
Micallef Jacob Vincent, Chief Scientific Officer
Plummer Nicholas, GC - Volition Diagnostics
Rubin Ethel, Director

How to read Form 4 transaction codes